South Korea IPO boom continues as shares in vaccine firm SK Bioscience surge 30% on debut reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
South Korea IPO boom continues as shares in vaccine firm SK Bioscience surge 30% on debut reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
South Korean vaccine developer SK Bioscience Co Ltd is expected to raise 1.5 trillion won ($1.33 billion) in the country's largest IPO since 2017, after pricing the listing at the top of an indicative range, it said on Monday.